Brief: RenovoRx Announces $11.1 Mln At Market Private Placement
April 8 (Reuters) - RenovoRx Inc RNXT.O :
* RENOVORX ANNOUNCES $11.1 MILLION AT MARKET PRIVATE
PLACEMENT
* RENOVORX INC - CASH POSITION NOW EXPECTED TO FUND CURRENT
OPERATING PLAN INTO 2026
* RENOVORX INC - PROCEEDS FROM FINANCING ARE ALSO EXPECTED
TO
ENABLE EXPANSION OF TAMP CLINICAL DEVELOPMENT PIPELINE INTO
ADDITIONAL CANCER INDICATIONS
Source text for Eikon: ID:nBw24w2Wxa
Further company coverage: RNXT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on RenovoRx
See all newsBrief: RenovoRx Gets FDA Orphan Drug Designation For Oxaliplatin To Treat Pancreatic Cancer
RenovoRx Q1 revenue rises as number of active cancer centers increase
RenovoRx 2025 net loss widens on higher operating expenses
Brief: RenovoRx FY Net Income USD -11.168 Million
U.S. STOCKS ON THE MOVE-Vertex Pharma, U.S. Energy Corp, SoFi Technologies